WHO Drug Information - Volume 37, No. 4

Overview

The fourth issue of Volume 37, includes

Consultation Documents:

  • IAEA/WHO Good manufacturing practices for in-house cold kits for radiopharmaceutical preparations
  • WHO Biowaiver project – prioritization exercise of Active Pharmaceutical Ingredients for cycle VI (2024) and preliminary results for cycle V (2023)
  • Fludeoxyglucose (18F) injection (Fludeoxyglucosi (18F) solution injectabilis)

ATC/DDD Classification:

  • ATC/DDD Classification (Temporary)
  • ATC/DDD Classification (Final)

The fourth issue of Volume 37, concludes with:

International Nonproprietary Names (INN) Proposed List No. 130

 

 


     

    WHO Team
    Access to Medicines and Health Products (MHP), INN and Classification of Medical Products (INN), Prequalification (PQT), Regulation and Prequalification (RPQ), Regulation and safety (REG)
    Editors
    World Health Organization
    Number of pages
    362
    Reference numbers
    ISBN: 978-92-4-008996-9
    Copyright